Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

Author： Cocquyt V.   Van Belle S.   Reinhardt R.R.   Decramer M.L.A.   O'Brien M.   Schellens J.H.M.   Borms M.   Verbeke L.   Van Aelst F.   De Smet M.   Carides A.D.   Eldridge K.   Gertz B.J.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.37, Iss.7, 2001-05, pp. : 835-842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis

By Tsukada H.   Hirose T.   Yokoyama A.   Kurita Y.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2398-2404

Elsevier

Access to resources Recommend Favorite

An Open Randomised Cross-over Study on Granisetron Versus Ondansetron in the Prevention of Acute Emesis Induced by Moderate Dose Cisplatin-containing Regimens

By Martoni A.   Angelelli B.   Guaraldi M.   Strocchi E.   Pannuti F.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 82-85

Elsevier

Access to resources Recommend Favorite

Oral Ondansetron in the Prevention of Chemotherapy-induced Emesis in Breast Cancer Patients

By Clavel M.   Bonneterre J.   d'Allens H.   Paillarse J.-M.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis

By Garcia-del-Muro X.   Vadell C.   Perez Manga G.   Bover I.   Rifa J.   Beltran M.   Barros M.a.M.   Germa J.R.   Fabregat X.   Moreno V.   Salvador A.   Viladiu P.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 193-195

Elsevier

Access to resources Recommend Favorite

Ondansetron for the Control of Dacarbazine-induced Emesis

By Campora E.   Chiara S.   Aschele C.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1720-1721

Elsevier

Access to resources Recommend Favorite